## **Core Concept**
The patient's history of intravenous drug use and serologic studies positive for HBsAg and anti-HCV indicate a chronic infection with both hepatitis B virus (HBV) and hepatitis C virus (HCV). Hepatocellular carcinoma (HCC) is a well-known complication of chronic liver disease, particularly in the context of chronic viral hepatitis.

## **Why the Correct Answer is Right**
The correct answer, , implies that the integration of HBV DNA into the host genome is a key factor. HBV has a unique life cycle that includes the integration of its DNA into the host liver cell genome. This integration can lead to genetic instability, disruption of tumor suppressor genes, and activation of oncogenes, contributing to the development of hepatocellular carcinoma. Chronic HBV infection is associated with a higher risk of HCC, and the integration of HBV DNA into the host genome is a well-documented mechanism facilitating carcinogenesis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not provide a mechanism directly related to the development of HCC in the context of viral hepatitis.
- **Option B:** While HCV can cause chronic liver disease and increase the risk of HCC, the specific mechanism mentioned does not directly address why this patient developed HCC as clearly as the integration of HBV DNA.
- **Option C:** This option is incorrect because it does not provide a relevant mechanism for HCC development in this context.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that chronic infection with HBV and HCV significantly increases the risk of developing hepatocellular carcinoma. The integration of HBV DNA into the host genome is a critical factor in the development of HCC in HBV-infected individuals. Screening for HCC is recommended in patients with chronic liver disease, including those with HBV and HCV infections.

## **Correct Answer: D. Integration of HBV DNA into the host genome.**